Vista Exclusive Content
Why Is Pfizer Reorganizing Into Three Businesses?
Pfizer (PFE) is a leading global provider of anti-infective medicines, offering patients access to a diverse portfolio of more than 80 products. Pfizer Inc. is set to organize the company into three businesses. The first, a science-based Innovative Medicines business that will also include biosimilars;
Breast Cancer Innovator Atossa Genetics Adds Former Pfizer & Boehringer Ingelheim Execs To New Strategic Advisory Board
Seattle based Atossa Genetics Inc. (ATOS) is a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods to treat breast cancer and other breast conditions. Today Atossa announced the formation of a strategic advisory board (SAB) comprised of prominent executives from the pharmaceutical industry. The
Learn More About The AACR Annual Meeting 2018: “Driving Innovative Cancer Science to Patient Care”
The mission of the American Association for Cancer Research (AACR) is to prevent and cure cancer through research, education, communication, and collaboration. Through its programs and services, the AACR fosters research in cancer and related biomedical science; accelerates the dissemination of new research findings among
Company News Around The Web
17 July 2018 | 7:15 pm
Pfizer's Hemophilia B Gene Therapy Candidate Enters...
Pfizer (PFE) initiates phase III program on a gene therapy t...
17 July 2018 | 3:33 pm
TD Ameritrade: Setting Time Target Best Way...
Geopolitical tensions are rising, and trade disagreements ar...
17 July 2018 | 2:30 pm
Johnson & Johnson CEO defends drug prices,...
Johnson & Johnson CEO Alex Gorsky called for changes in ...
17 July 2018 | 1:53 pm
How Johnson & Johnson Became A Household...
New Brunswick, N.J.-based Johnson & Johnson (NYSE: JNJ...
16 July 2018 | 10:50 pm
Increasing drug prices despite public scrutiny 'makes...
Some drug companies continue to raise prices, despite mounti...
16 July 2018 | 8:16 pm
Pfizer begins late-stage testing of Spark's hemophilia...
The two companies, which said a licensing deal in 2014, have...
|Day Low - High||-|
|Year Low - High||-|